Most Active Stories
- Crashed Air Force drone was flying with gear that couldn't handle cold
- Schumer hopes federal funds will help local brewpub expand
- Teachers union not ready to reverse no confidence vote in education commissioner
- Small group protests possibility of housing Central American immigrants in Syraucse
- Air Force plane found deep below Lake Ontario from 1952 crash
Novartis Loses Patent Battle In India
Originally published on Fri April 5, 2013 8:50 am
STEVE INSKEEP, HOST:
NPR's business news starts with a patent ruling that may affect millions.
(SOUNDBITE OF MUSIC)
INSKEEP: The ruling comes from the supreme court of India, a country with a population somewhere north of a billion. The Indian supreme court rejected patent rights claimed by the pharmaceutical giant Novartis. This ruling opens the door for Indian drug makers to produce generic versions of Novartis' lifesaving cancer drugs and will make the medicine more affordable for people in developing nations. Transcript provided by NPR, Copyright NPR.